Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005938
What this trial is testing

DX-8951f in Treating Patients With Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Daiichi Sankyo
Not applicableLooking for participantsNCT07079150
What this trial is testing

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Who this might be right for
Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University 1,500
Testing effectiveness (Phase 2)UnknownNCT04368078
What this trial is testing

Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 76
Not applicableStudy completedNCT00764140
What this trial is testing

Tumor Growth Factors in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 400
Testing effectiveness (Phase 2)UnknownNCT05962450
What this trial is testing

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 84
Early research (Phase 1)Ended earlyNCT03349255
What this trial is testing

Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more
Aeon Therapeutics (Shanghai) Co., Ltd. 3
Not applicableLooking for participantsNCT05623150
What this trial is testing

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisAlcohol-related Liver Disease+2 more
Institut National de la Santé Et de la Recherche Médicale, France 710
Not applicableUnknownNCT05021250
What this trial is testing

SBRT With DIBH for HCC After TACE and Lipiodol Marking

Who this might be right for
Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT06492408
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

Who this might be right for
Hepatic CancerSurgery
Second Affiliated Hospital of Guangzhou Medical University 90
Not applicableEnded earlyNCT01507740
What this trial is testing

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Who this might be right for
Hepatocellular CancerNon-small Cell Lung CancerRenal Cell Cancer+1 more
Medical University Innsbruck 60
Testing effectiveness (Phase 2)UnknownNCT04157140
What this trial is testing

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Jinglong Chen 48
Testing effectiveness (Phase 2)Ended earlyNCT03630640
What this trial is testing

Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation

Who this might be right for
Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 43
Testing effectiveness (Phase 2)Ended earlyNCT03785210
What this trial is testing

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05113186
What this trial is testing

Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative

Who this might be right for
Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 32
Testing effectiveness (Phase 2)Study completedNCT03753659
What this trial is testing

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 30
Testing effectiveness (Phase 2)Study completedNCT02447679
What this trial is testing

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Who this might be right for
Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaAdverse Reaction to Drug+1 more
Chang Gung Memorial Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Very early researchStudy completedNCT03291379
What this trial is testing

Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies

Who this might be right for
Carcinoma, HepatocellularMetastatic Colorectal Cancer
Boston Scientific Corporation 8
Large-scale testing (Phase 3)UnknownNCT03313596
What this trial is testing

Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Huazhong University of Science and Technology 180
Not applicableEnded earlyNCT02847468
What this trial is testing

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Who this might be right for
Carcinoma, Hepatocellular
Centre Georges Francois Leclerc 61
Next Page